Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists

OBJECTIVE: Screening for hepatitis B virus (HBV) before chemotherapy is recommended by international guidelines; still, the HBV screening rate is low, and patients remain at risk for HBV reactivation (HBVr). Because HBVr is a serious and preventable condition, we conducted a survey to evaluate the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Leber, Karin, Otten, Hans‐Martin J. M. M. B., Brandjes, Dees P. M., Claassen, Mark A. A., Lauw, Fanny N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285452/
https://www.ncbi.nlm.nih.gov/pubmed/34310787
http://dx.doi.org/10.1111/ecc.13495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285452/
https://www.ncbi.nlm.nih.gov/pubmed/34310787
http://dx.doi.org/10.1111/ecc.13495

Ejemplares similares